Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

EU-PFF NEWS

Next webinar on Oct 23: Pulmonary Hypertension associated with interstitial lung disease (PH-ILD) – current and future treatments

18 Oct 2023 - 10:10

Share this

     

The 4th session of a new series of monthly and free webinars for the pulmonary fibrosis community will take take place on October 23rd at 19:00 CET.

Many Pulmonary Fibrosis patients develop pulmonary hypertension (PH), which can result in rapid worsening of symptoms and lower life expectancy. Dr Lucilla Piccari, Barcelona, Spain, Prof David Kiely, Sheffield, UK, and Hall Skaara, PHA Europe, will discuss what is known about PH-ILD, as well as current and potential treatments. The session will be moderated by Steve Jones, EU-PFF President.

The 4th webinar will be held on: Oct 23rd 2023 | 19:00-20:00 CET | 18:00-19:00 BST | 1:00-2:00 PM Eastern Time

Click here to register. 

The live webinar will be held in English. The recording will be released later with subtitles in various languages.

This series of webinars are kindly supported by an unrestricted grant from Boehringer Ingelheim, Trevi Therapeutics, Chiesi Farmaceutici and the Roche Group.

Data Policy:
The data provided by you (name & email address) will be used exclusively to inform you about our activities, future events, our webinars and, if applicable, other events and projects relevant to the PF community, and will not be passed on to third parties under any circumstances. By registering for this webinar, you consent to these terms. Consent for use of your data for those purposes can be withdrawn any time by an email to secretariat@eu-pff.org

Related News & Events

New President Elected!

New President Elected!

The European Pulmonary Fibrosis Federation (EU-PFF) is pleased to announce the appointment of John...